From: Serum magnesium level and cardiac valve calcification in hemodialysis patients
Items | Results |
---|---|
Male (%) | 60 (56.6) |
Age (years) | 62.1 ± 13.5 |
Smoking (%) | 28 (26.4) |
Dialysis duration (months) | 58.8 ± 45.4 |
DM (%) | 61 (57.5) |
LEAO (%) | 19 (17.9) |
CHD (%) | 56 (52.8) |
CAC (%) | 58 (54.7) |
CVC (%) | 68 (64.8) |
AVC (%) | 67 (63.8) |
MVC (%) | 26 (24.8) |
TVC (%) | 0 (0) |
AVC + MVC (%) | 25 (23.8) |
Combined tumor (%) | 13 (12.4) |
Kt/V | 1.40 ± 0.27 |
GFR (ml/min/1.73 2 ) | 4.71 ± 1.46 |
Serum UA (µmol/L) | 454.1 ± 68.9 |
Serum Ca (mmol/L) | 2.18 ± 0.15 |
Serum P (mmol/L) | 1.89 ± 0.39 |
Serum K (mmol/L) | 4.97 ± 0.51 |
Serum Na (mmol/L) | 139.7 ± 2.7 |
Serum Mg (mmol/L) | 1.11 ± 0.13 |
Hb (g/L) | 117.4 ± 10.5 |
PTH (ng/L) | 267.2 ± 154.7 |
ALP (U/L) | 80.8 ± 32.8 |
TP (g/L) | 65.5 ± 4.7 |
Alb (g/L) | 40.1 ± 2.8 |
Pre-Alb (mg/L) | 324.8 ± 60.7 |
TC (mmol/L) | 3.70 ± 1.04 |
TG (mmol/L) | 2.05 ± 1.15 |
LDL-C (mmol/L) | 1.96 ± 0.85 |
HDL-C (mmol/L) | 0.93 ± 0.27 |
Drug | |
Calcium carbonate (%) | 33 (31.1) |
Lanthanum carbonate (%) | 14 (13.2) |
Sevelamer (%) | 43 (40.6) |
Cinacalcet (%) | 20 (18.9) |
Calcitriol or Paricalcitol (%) | 50 (47.2) |